1. Financial Highlights: Consolidated revenues rose 4.5% YoY to ₹5612 Cr in FY25, supported by shrimp feed and processed shrimp segments.

Q4 revenues increased 8% YoY to ₹1385 Cr.

EBITDA jumped 34% YoY to ₹799 Cr, with margin expanding to 14.2% from 11.1%. PAT surged 41.5% YoY to ₹557 Cr, lifting margins to 9.9%. Q4 PAT was ₹157 Cr with 11.3% margin.

EPS stood at ₹38.8 for FY25 and ₹11.1 for Q4. The balance sheet is strong with reserves at ₹3161 Cr and net debt almost nil.

Return ratios improved—RoE at 19% and RoCE at 23%. 2. Strategic Initiatives & Growth Drivers: Shrimp feed volumes grew 4% YoY, boosting revenue and margin to 15.3%. The product portfolio expanded through Avanti Pet Care’s launch of “Avant Frust” cat food, signaling diversification.

Shrimp processing volumes surged 23% to 16,248 MT on better realizations and forex gains.

Capex focus remains on scaling production and processing capacity to capture volume and pricing opportunities.

3. Business Developments: No major acquisitions or partnerships announced.

The key development is venturing into pet nutrition with the new cat food brand under a subsidiary, broadening beyond core shrimp feed and processing.

4. Market Position & Competitive Advantage: Avanti continues to lead the shrimp feed industry with scale and volume growth.

The processing segment benefits from diversified exports, mainly to North America (~70%), with steady Europe and Asia sales.

The company’s integrated shrimp feed and processing model supports robust margins despite external headwinds.

5. Investor Implications: Volume growth, margin expansion, and product diversification suggest positive growth potential.

A strong balance sheet and improved returns underpin financial stability.

Execution on pet nutrition scale-up and global trade dynamics remain key areas for investors to watch.